Navigation Links
Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety
Date:3/21/2013

Philadelphia, PA (PRWEB) March 21, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients who have taken the diabetes drug Actos. In an ongoing trial over Actos bladder cancer side effects*, a former employee recently alleged in testimony that drug maker Takeda put profit concerns over safety.

DrugRisks was created to provide those taking popular prescription drugs with the latest safety alerts, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice for current litigation.

Health experts with the FDA** and European Medicines Agency*** have warned patients that long-term use of Actos may be linked to increased risks of bladder cancer. The drug has also been banned in France and Germany****.

The maker of Actos, Takeda Pharmaceuticals, now faces Actos lawsuits from as many as 3,000 patients over bladder cancer*****. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California.

DrugRisks has added information showing the first Actos lawsuit trial in California* began this month for a man dying of bladder cancer*****. Also, a former pharmacologist for Takeda testified that company emails suggested they were more concerned with continued sales of the drug rather than the safety of patients*****.

Although trials have begun, lawyers are still helping those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Safety Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.
Visit http://www.DrugRisks.com today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*Cooper v. Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles)
**http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm
***http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/human_pha_detail_000033.jsp&mid=WC0b01ac058001d126&source=homeMedSearch&category=human
****cbsnews.com/8301-504763_162-20070492-10391704.html
*****bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html

Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-lawsuits/prweb10547940.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New ASTRO white paper recommends peer review to increase quality assurance and safety
2. Studies for approval of new drugs have insufficient patients to evaluate safety
3. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
4. New Guidelines Raise Safety Bar on Concussions
5. Report: Communications technology among tools needed to aid miner safety
6. The Healthy Facilities Institute (HFI) Forms Educational Partnership with the National Floor Safety Institute (NFSI)
7. ERs Not Doing Enough to Educate Parents on Car-Seat Safety: Study
8. Space Heater Safety Tips Can Help Prevent Burns, Fires
9. Internet searches can identify drug safety issues well ahead of public alerts
10. Emergency departments not doing enough to educate parents about car seat safety
11. Report Details Steps to Boost Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Petersburg, FL (PRWEB) , ... April 29, 2016 , ... Sublime Beauty® is offering a ... the same product) for 50% off. The discount is applied to the product with lesser ... is given to those who purchase $250 or more in products. , "So many women ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ProText Layouts is ... Final Cut Pro X . With ProText Layouts, video editors can create an ... match the length and scale of texts. Creating text-based videos have never been ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ARRS ... attracting medical professionals from around the globe who attended a week’s worth of ... Sunday, April 17 included the introduction of the 2016 ARRS Distinguished Educator, Dr. ...
(Date:4/28/2016)... ... 28, 2016 , ... Greener Hydroponics is now offering a large selection of ... professional organic farmers and nurseries according to Sales Manager Joe Steele who says, “Now ... goal is to offer wholesale level pricing and ultra-fast shipping for growers of any ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
Breaking Medicine Technology: